Gene · 51
Papers2,671
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,671
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a Novel Heterozygous Mutation in the EIF2B4 Gene Associated With Vanishing White Matter Disease. | Front Bioeng Biotechnol | 2022 | 35860328 | PubTator, text mining | PubMed |
| Effects of macrophages on the proliferation and cardiac differentiation of human induced pluripotent stem cells. | Cell Commun Signal | 2022 | 35850719 | PubTator, text mining | PubMed |
| Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application. | Front Oncol | 2022 | 35847898 | PubTator, text mining | PubMed |
| Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity. | Nat Commun | 2022 | 35842425 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Biotransformation novel advances - 2021 year in review. | Drug Metab Rev | 2022 | 35815654 | PubTator, text mining | PubMed |
| Biochemical Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of Mitochondrial Dysfunction. | Cells | 2022 | 35805129 | PubTator, text mining | PubMed |
| Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5. | J Med Chem | 2022 | 35802779 | PubTator, text mining | PubMed |
| The gene knockout of angiotensin II type 1a receptor improves high-fat diet-induced obesity in rat via promoting adipose lipolysis. | PLoS One | 2022 | 35802723 | PubTator, text mining | PubMed |
| CircASPH Promotes Hepatocellular Carcinoma Progression Through Methylation and Expression of HAO2. | Front Oncol | 2022 | 35795047 | PubTator, text mining | PubMed |
| Inhibition of autophagy with expression of NADPH oxidase subunit p22phox in preneoplastic lesions in a high-fat diet and streptozotocin-related hepatocarcinogenesis rat model. | J Toxicol Sci | 2022 | 35786680 | PubTator, text mining | PubMed |
| Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments. | Front Cardiovasc Med | 2022 | 35783870 | PubTator, text mining | PubMed |
The Human Milk Oligosaccharide 2'-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice. | Front Nutr | 2022 | 35782914 | PubTator, text mining | PubMed |
| Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method. | Fluids Barriers CNS | 2022 | 35778717 | PubTator, text mining | PubMed |
| Experimental Setup for Investigation of Acute Mitochondrial Oxygen Sensing in Primary Cells. | Methods Mol Biol | 2022 | 35771451 | PubTator, text mining | PubMed |
| Differential proteomics of placentas reveals metabolic disturbance and oxidative damage participate yak spontaneous miscarriage during late pregnancy. | BMC Vet Res | 2022 | 35761325 | PubTator, text mining | PubMed |
| Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential. | Oxid Med Cell Longev | 2022 | 35757505 | PubTator, text mining | PubMed |
| Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. | Front Oncol | 2022 | 35756670 | PubTator, text mining | PubMed |
| Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models. | PPAR Res | 2022 | 35754743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51/papers?page=33